Jason P Rhodes insider trades: Dyne Therapeutics (DYN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
32 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | DYN | ↓ Sell | 2,586,928 | $25.20 | $65.2M | Indirect | Aug 17, 2026 (3d) |
| Jul 7, 2026 | DYN | ↓ Sell | 777,451 | $22.97 | $17.9M | Indirect | Jul 8, 2026 (1d) |
| Jun 29, 2026 | DYN | ↓ Sell | 504,695 | $21.23 | $10.7M | Indirect | Jun 30, 2026 (1d) |
| May 6, 2026 | DYN | ↓ Sell | 106,723 | $18.14 | $1.9M | Indirect | May 6, 2026 (0d) |
| Apr 28, 2026 | DYN | ↓ Sell | 227,337 | $18.38 | $4.2M | Indirect | Apr 30, 2026 (2d) |
| Apr 22, 2026 | DYN | ↓ Sell | 834,302 | $19.75 | $16.5M | Indirect | Apr 22, 2026 (0d) |
| Nov 14, 2024 | DYN | ↓ Sell | 782 | $33.10 | $26K | Indirect | Nov 18, 2024 (4d) |
| Mar 1, 2024 | DYN | ↓ Sell | 46,534 | $30.05 | $1.4M | Indirect | Mar 5, 2024 (4d) |
| Feb 28, 2024 | DYN | ↓ Sell | 807,838 | $24.30 | $19.6M | Indirect | Feb 28, 2024 (0d) |
| Feb 23, 2024 | DYN | ↓ Sell | 500,789 | $22.64 | $11.3M | Indirect | Feb 23, 2024 (0d) |
| Feb 20, 2024 | DYN | ↓ Sell | 510,152 | $23.26 | $11.9M | Indirect | Feb 20, 2024 (0d) |
| Dec 12, 2022 | DYN | ↑ Buy | 934,581 | $10.70 | $10.0M | Indirect | Dec 14, 2022 (2d) |
| Sep 29, 2021 | GBIO | ↓ Sell | 81,088 | $25.40 | $2.1M | Indirect | Sep 29, 2021 (0d) |
| Sep 24, 2021 | GBIO | ↓ Sell | 134,998 | $26.02 | $3.5M | Indirect | Sep 24, 2021 (0d) |
| Jun 24, 2021 | GBIO | ↓ Sell | 31,008 | $25.85 | $802K | Indirect | Jun 28, 2021 (4d) |
| Jun 23, 2021 | GBIO | ↓ Sell | 185,078 | $25.05 | $4.6M | Indirect | Jun 23, 2021 (0d) |
| Apr 14, 2021 | GBIO | ↓ Sell | 140,682 | $25.92 | $3.6M | Indirect | Apr 14, 2021 (0d) |
| Apr 9, 2021 | GBIO | ↓ Sell | 127,095 | $28.20 | $3.6M | Indirect | Apr 9, 2021 (0d) |
| Jan 26, 2021 | REPL | ↓ Sell | 5,558 | $46.14 | $256K | Indirect | Jan 28, 2021 (2d) |
| Dec 18, 2020 | REPL | ↓ Sell | 4,319 | $41.95 | $181K | Indirect | Dec 22, 2020 (4d) |
| Dec 17, 2020 | REPL | ↓ Sell | 65,029 | $42.28 | $2.7M | Indirect | Dec 17, 2020 (0d) |
| Dec 14, 2020 | REPL | ↓ Sell | 103,686 | $43.35 | $4.5M | Indirect | Dec 14, 2020 (0d) |
| Dec 9, 2020 | REPL | ↓ Sell | 217,362 | $45.92 | $10.0M | Indirect | Dec 9, 2020 (0d) |
| Nov 18, 2019 | REPL | ↑ Buy | 1,100,000 | $13.61 | $15.0M | Indirect | Nov 20, 2019 (2d) |
| Sep 2, 2014 | EPZM | ↓ Sell | 30,000 | $33.47 | $1.0M | Direct | Sep 4, 2014 (2d) |
| Aug 4, 2014 | EPZM | ↓ Sell | 30,000 | $29.74 | $892K | Direct | Aug 5, 2014 (1d) |
| Jul 7, 2014 | EPZM | ↓ Sell | 30,000 | $32.74 | $982K | Direct | Jul 9, 2014 (2d) |
| Jun 2, 2014 | EPZM | ↓ Sell | 30,000 | $22.20 | $666K | Direct | Jun 4, 2014 (2d) |
| May 5, 2014 | EPZM | ↓ Sell | 30,000 | $21.53 | $646K | Direct | May 5, 2014 (0d) |
| Apr 7, 2014 | EPZM | ↓ Sell | 25,000 | $20.05 | $501K | Direct | Apr 8, 2014 (1d) |
| Feb 10, 2014 | EPZM | ↓ Sell | 50,000 | $29.25 | $1.5M | Direct | Feb 12, 2014 (2d) |
| Jan 6, 2014 | EPZM | ↓ Sell | 10,000 | $20.19 | $202K | Direct | Jan 6, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DYN insiders
Open-market trades in the last 12 months
About Jason P Rhodes's insider trades
Jason P Rhodes is an insider at Dyne Therapeutics (DYN). Since Jan 6, 2014, Jason has reported 2 open-market purchases worth $25.0M and 30 sales worth $202.9M on SEC Form 4. In the last 12 months: 6 sales ($116.3M).
Their filings also include grants and awards (21 filings), option exercises (9 filings), conversions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DYN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.